Please Note - Streaming News is only available to subscribers to the Active Level and above
Director Deals - Silence Therapeutics PLC (SLN)
BFN
Mark Rothera, Chief Executive Officer, bought 3,000 shares in the company on the 1st December 2020 at a price of $6.10. The Director now holds 17,100 shares.
Story provided by StockMarketWire.com
Director deals data provided by www.sharesmagazine.co.uk
